Julia Bonavitacola

The increased costs of premiums after the expiration of enhanced subsidies have led to an increased percentage of those not able to make their payments.

New results show that reproxalap did not cause any serious treatment-related adverse events in patients living with dry eye disease.

Psychological effects of alopecia areata should be looked into in the future for patients who live with the condition.

Both Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scores improved after treatment.

Poor outcomes could be predicted based on the presence of ectopic germinal centers in the thymus in patients with thymoma-associated myasthenia gravis.

Sequential therapy of ranibizumab and a dexamethasone implant improved results in macular edema secondary to non–ischemic retinal vein occlusion.

Despite decreases in therapy use, hospitalizations for multiple sclerosis and neurologist visits were not affected significantly.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Adults can undergo CAR T-cell therapy for relapsed or refractory mantle cell lymphoma after the full approval of the treatment.

The US has seen approximately 370 cases of mpox through March 2026, indicating a consistent need to diagnose the illness.

Lower actual wearable use was found in patients with multiple sclerosis (MS) despite comparable intentions to use the wearable technology.

There were few incidences of complications in the follow-up period after the MicroShunt was implanted in the patient.

TrumpRx launched in early February with the aim to offer lower-priced drugs to those without insurance or those who would like to pay in cash. The results are more complicated.

The study, evaluating the efficacy of the combination of efgartigimod alfa and hyaluronidase-qvfc, is the first to specifically evaluate those with ocular myasthenia gravis.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The incidence of very late onset of myasthenia gravis has increased in the past 50 years, which has had implications on prognosis.

Increased health care costs, use of nonsteroidal immunosuppressants, and elevated health care costs were associated with use of glucocorticoids by patients with myasthenia gravis.

Smoking cessation, abnormal weight, and socioeconomic deprivation were all associated with mortality in multiple sclerosis.

The prevalence of retinal conditions in the US varied by region, race and ethnicity, and sex, which could identify areas of need.

Maria Hordinsky, MD, discusses the promise of Janus kinase (JAK) inhibitors in treating alopecia areata in the long term.

Maria Hordinsky, MD, discusses exciting results in alopecia areata, including some discussed at the Winter Clinical Dermatology Conference.

Disparities in health system performance were larger by income in the US, indicating a need for structural and systemic policy efforts.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A survey of marketplace enrollees revealed that they expect to cut back on basic household expenses to keep insurance coverage.

Patients with primary biliary cholangitis (PBC) can use linerixibat to address cholestatic pruritus, which up to 89% of patients with PBC experience.

Patients with multiple sclerosis valued both occupational therapy and physiotherapy as means of addressing their condition.

The complete response letter marks the second time that reproxalap, a medication for use in dry eye disease, has been rejected by the FDA.

Severe COVID-19 was rare in patients with multiple sclerosis even when vaccine responses were impaired.

Legislation that passed the Senate will introduce reform in how pharmacy benefit managers are addressed by CMS starting in 2028.

The website officially launched on February 5, introducing a key part of the Trump administration’s health care plan.